The Effects of Single Baduanjin and Elastic Band Exercises on VSWM in Elderly Individuals With MCI
14. juni 2026 oppdatert av: qiu chen
The Effects of Single Baduanjin and Elastic Band Exercises on Visuospatial Working Memory in Elderly Individuals With Mild Cognitive Impairment
Previous studies have confirmed that both acute (single) and long-term various exercise interventions can significantly improve the cognitive function of individuals with MCI.
The positive effects of long-term Qigong and elastic band exercises have also been verified.
There are relatively few studies on the impact of Qigong and elastic band exercises on working memory.
Most studies focusing on working memory mainly target children and college students.
The effect of these exercises on the elderly has not been proven, and the improvement mechanism has not been clarified either.
This article mainly starts from a single exercise perspective to explore whether a single exercise can improve the VSWM of elderly individuals with MCI.
From the perspective of neurophysiology, it also discusses the brain mechanism of single Qigong and elastic band exercises on the working memory of cognitively impaired elderly people, providing reference for future long-term exercise prescriptions for the treatment and prevention of Alzheimer's disease in China.
Studieoversikt
Status
Har ikke rekruttert ennå
Forhold
Intervensjon / Behandling
Studietype
Intervensjonell
Registrering (Antatt)
60
Fase
- Ikke aktuelt
Kontakter og plasseringer
Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.
Studiekontakt
- Navn: chen qiu
- Telefonnummer: 86+13964805297
- E-post: q13964805297@163.com
Deltakelseskriterier
Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
- Voksen
- Eldre voksen
Tar imot friske frivillige
Nei
Beskrivelse
Inclusion Criteria:
- Include the elderly population aged between 60 and 74 years old.
- Includes individuals with cognitive impairments. The patients or informants report experiencing memory decline and having certain cognitive dysfunction (MoCA score = 18-25 points).
- Including individuals who have controlled diabetes and/or cardiovascular diseases to a stable state.
- Irregular exercise with the ability to complete a certain amount of physical activities.
- Normal vision and hearing.
Exclusion Criteria:
- Patients with moderate to severe cognitive impairment, mental illness or other neurodegenerative diseases (such as Parkinson's dementia, stroke, frontotemporal degeneration, vascular dementia, Lewy body dementia, etc.).
- Long-term or recent use of psychotropic drugs, drugs that affect physical activity ability, cholinergic inhibitors, etc.
- Regular exercise habit .
- There are serious muscle disorders, or there has been an injury to the lower limbs within the previous six months, making it impossible to stand for a long time or to stand at all.
- Severe cardiovascular disease.
Studieplan
Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Behandling
- Tildeling: Randomisert
- Intervensjonsmodell: Parallell tildeling
- Masking: Enkelt
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
|---|---|
|
Ingen inngripen: styre
|
|
|
Eksperimentell: baduanjin
|
Perform the 30-minute Baduanjin exercise
|
|
Eksperimentell: Resistance band
|
Perform 30 minutes of elastic band exercises
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
visuo-spatial working memory
Tidsramme: From July 1, 2026, to September 1, 2026, the duration is two months.
|
The primary research outcome pertains to visuospatial working memory, which is measured through a visuospatial working memory task paradigm.
The specific paradigm is as follows: First, a "+" appears in the middle of a gray computer screen for 300 ms.
Second, a 4x4 grid matrix appears at the center of the screen for 2000 ms, with 5 small black squares randomly placed within the matrix.
Immediately afterwards, a blank screen is presented for 3000 ms.
During this period, the participants are required to mentally visualize the probe stimulus after rotating it 90° to the left (or right).
Subsequently, a 4x4 grid target stimulus is presented again for 4000 ms, and the participants need to make a judgment on the target stimulus, specifically whether it is the result of rotating the probe stimulus 90° to the left (or right), as shown in Figure 3.
The entire experiment lasts approximately 8 minutes.
|
From July 1, 2026, to September 1, 2026, the duration is two months.
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
EEG power value
Tidsramme: The total duration was two months.
|
The testers adjusted the impedance to below 5kΩ and followed the 26-system electrode placement method specified by the International Federation of Electroencephalography.
They set Fp1, Fp2, F3, F4, F7, F8, Fc3, Fc4, C3, C4, Cp3, Cp4, P3, P4, Pz, O1, O2, Oz, Po3, Po4, T3, T4, T5, and T6 leads.
The ground electrode was set as GND, and the reference electrode was at the bilateral earlobe positions of A1 and A2.
After stabilization, they began to record the EEG signals for 5 minutes.
Using the toolbox, they filtered out data segments with obvious artifact interference.
They analyzed the EEG indicators, including frontal cortex δ-β2 (Fp1, Fp2, F3, F4, F7, F8, AF3, AF4, Fc3, Fc4), central cortex δ-β2 (C3, C4, Cp3, Cp4), parietal cortex δ-β2 (P3, P4, Pz), occipital cortex δ-β2 (O1, O2, Oz, Po3, Po4), and temporal cortex δ-β2 (T3, T4, T5, T6).
|
The total duration was two months.
|
Samarbeidspartnere og etterforskere
Det er her du vil finne personer og organisasjoner som er involvert i denne studien.
Sponsor
Studierekorddatoer
Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.
Studer hoveddatoer
Studiestart (Antatt)
1. juli 2026
Primær fullføring (Antatt)
1. september 2026
Studiet fullført (Antatt)
14. september 2026
Datoer for studieregistrering
Først innsendt
27. mai 2026
Først innsendt som oppfylte QC-kriteriene
14. juni 2026
Først lagt ut (Faktiske)
18. juni 2026
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
18. juni 2026
Siste oppdatering sendt inn som oppfylte QC-kriteriene
14. juni 2026
Sist bekreftet
1. juni 2026
Mer informasjon
Begreper knyttet til denne studien
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- 183551747
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
NEI
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Nei
Studerer et amerikansk FDA-regulert enhetsprodukt
Nei
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .